Vaccine treatment evaluation units (vteu's)

Ended Awarded Last action

Contract number
HHSN27200003
Awardee
Awarding agency
Obligated
$2,054,103

Award facts

Opportunity
Contract value 100% obligated
$2,054,102.82 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Baltimore, MD 21201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00009 -$274,328
Supplemental Agreement for work within scope P00008 · University of maryland, baltimore, vaccine and treatment evaluation unit (VTEU) contract HHSN272201300022I and task order HHSN27200003-13-0088.B1C1.0003. $0
Funding Only Action P00007 · The purpose of this modification is to deobligate expired FY15 funds from TA C-1, to replace those funds through a reobligation of FY21 funds, and update… $0
Funding Only Action P00006 · The purpose of this modification is to extend the period of performance and add funds to task area C option 1, as well as update various articles and clauses. $565,933
Funding Only Action P00005 $44,102
Funding Only Action P00004 $112,851
Funding Only Action P00003 -$16,841
Other Administrative Action 2 $0
Exercise an Option 1 $1,555,265
Original award $67,121

About this award

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) as the prime contractor. The contract is a delivery order under the Vaccine and Treatment Evaluation Units (VTEU) master Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The contract has a ceiling value of $2,054,102.82 and is focused on vaccine treatment evaluation. There is no small business set-aside designation for this award. As a sub-contract under the primary award, the University of Arkansas for Medical Sciences (UAMS) was selected to provide and operate a photoacoustic flow cytometry device to perform malaria diagnostics during controlled human malaria infection studies. The VTEU program supports the development and evaluation of vaccines and treatments for infectious diseases, leveraging the expertise of academic medical centers and research institutions across the United States.

Quick answers

Who was awarded contract HHSN27200003?

HHSN27200003 was awarded to University Of Maryland, Baltimore by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 5, 2014.

How much is contract HHSN27200003 worth?

The government has obligated $2,054,103 on HHSN27200003.

Is contract HHSN27200003 an order under another contract?

Yes. HHSN27200003 is a delivery order under HHSN272201300022I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).

Was contract HHSN27200003 competed?

The extent of competition for HHSN27200003 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award